checkAd

    DGAP-News  629  0 Kommentare B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN, AnalytiCon and Roquette sign a strategic partnership for the development of next generation natural sweetening solutions

    DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG /
    Key word(s): Alliance
    B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN,
    AnalytiCon and Roquette sign a strategic partnership for the development of
    next generation natural sweetening solutions

    29.08.2016 / 08:30
    The issuer is solely responsible for the content of this announcement.

    ---------------------------------------------------------------------------

    BRAIN, AnalytiCon and Roquette sign a strategic partnership for the
    development of next generation natural sweetening solutions

    - The three partners form the DOLCE consortium to address sugar and
    sweetening solutions challenge in different markets and applications.

    - Many of the largest Fortune 500 global consumer product goods companies
    are known to have significant interest in this field

    Zwingenberg, Potsdam (Germany) and Lestrem (France), August 29, 2016: The
    bioeconomy company BRAIN AG (ISIN DE0005203947 / WKN 520394), the natural
    product specialist AnalytiCon Discovery GmbH and Roquette, a global leader
    in specialty food ingredients from plant-based raw materials, announced
    today a strategic partnership under the form of a consortium by the name
    DOLCE. Within this unique strategic partnership, the partners will jointly
    develop natural sweeteners and sweet taste enhancers with the goal to
    achieve sugar- and calorie reduction in a variety of food and beverages.
    These developments will benefit the global market and will address pressing
    needs in terms of sugar replacement.

    Always striving for innovation, within the DOLCE consortium, Roquette
    intends to benefit from the proprietary BRAIN screening technology and
    AnalytiCon's access to a huge variety of all-natural ingredients with a
    particular focus on edible plant material. Roquette's role will be to take
    care of the late stage development, production and supply of the compounds
    to different markets and application fields.

    The goal of the DOLCE consortium is to develop cutting-edge natural sweet
    taste enhancers and sweeteners for nutrition and improved food formulations
    for their customers, and to deploy a brand strategy on the new solutions,
    addressing the requirements of global customers. Many of the largest
    Fortune 500 global consumer product goods companies (CPGC) are known to
    have strong interest in this field, and the market for consumer goods and
    beverages is expected to greatly benefit from the development of these new
    sweetening solutions.

    "In the field of food and beverages, there is a high demand for natural
    Seite 1 von 4


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN, AnalytiCon and Roquette sign a strategic partnership for the development of next generation natural sweetening solutions DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG / Key word(s): Alliance B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN, AnalytiCon and Roquette sign a strategic partnership for the development of next …